The purpose of this prospective observational study is to create a database in which data will be collected from every patient admitted to the Stroke unit and who has explicitly given his or her informed consent for this data collection. The data that will be collected are part of the standard clinical data. No additional investigations, blood tests or any other tests will be performed. The purpose of this database is to conduct retrospective observational research in the future and will allow the hospital to keep track of some important quality indicators in stroke care.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patients admitted to the Stroke unit with a cerebrovascular disease
* Patients admitted to the regular neurological ward or any other department in the University Hospital Ghent with a cerebrovascular disease who are actively followed by the department of Neurology during hospitalisation
* Patients who have given their explicit informed consent for data collection
Exclusion Criteria:
* Patients who have not given informed consent for data collection
* Patients who are not able to give informed consent and whose legal representative has not given informed consent
Primary outcome measure(s)
Characteristics of study population — date of inclusion until end of follow-up (12 months) Information about patients included in the stroke database: age, gender, medical/family history
Onset-to-door — date of inclusiondate of inclusion until end of follow-up (12 months) Time between stroke onset and arrival at Emergency Department
Patients treated with acute stroke therapy — date of inclusion until end of follow-up (12 months) Patients treated with acute stroke therapy (i.e. thrombolysis and/or thrombectomy), start time of acute therapy
Outcome after acute therapy — date of inclusion until end of follow-up (12 months) Outcome after acute therapy, assessed by NIHSS and mRS score, possible complications and imaging
Incidence of complications at stroke unit — date of inclusion until end of follow-up (12 months) Incidence of neurological complications, epilepsy, infections, falls, thrombo-embolic complications, cardiac complications, pain
Etiology of stroke — date of inclusion until end of follow-up (12 months) Etiology of stroke, with a distinction between ischaemic stroke, hemorrhagic stroke, subarachnoid stroke or other
Mortality and disability after admission to Stroke unit — date of discharge until end of follow-up (12 months) Mortality and (severity of) disability after admission to stroke unit
Trial sites (1)
Facility
City
Region
Status
Department of Neurology - Ghent University Hospital
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.